• Lifestyle
More

    Indian scientists inch closer to treating deadly fatty liver disease

    Must Read

    WR revise timings of 15 more special trains from 1st December

    Western Railway has revised the timings of some more special trains of Western Railway from 1st December,...

    WR to extend the run of six more festive special trains with 96 additional services

    For the convenience of passengers and meet the travel demand, Western Railway has decided to further extend...

    WR recovered ₹ 1.04 cr as penalty in intensive checking drives

    Western Railway’s Mumbai Division conducted various drives to check & deter unauthorized passengers travelling in trains. More...

     

    Advancing the hunt for elusive therapeutics against non-alcoholic fatty liver disease (NAFLD), the most common liver affliction across the globe, the Indian researchers have discovered a new mechanism through which the liver hoards up extra fat from sources other than alcohol.

    NAFLD affects more than 30 per cent adult Indians and occurs when more than 5 to 10 per cent of the liver’s weight is fat.

    They have also identified a brand new drug target for potential therapy for the disease, that tends to develop in people who are overweight or obese or have type-2 diabetes.

    There is no definite therapy for the disease.Moreover, a significant number of NAFLD patients progress to the most extreme form of the disease called non-alcoholic steatohepatitis (NASH), an irreversible clinical condition that causes the liver to swell and become damaged and trigger cirrhosis in adults.

    The senior researcher Partha Chakrabarti’s research group along with Saikat Chakrabarti’s laboratory at Indian Institute of Chemical Biology, a unit of CSIR, decided to take a shot at the silent, crippling disease that evolves over decades, its prevalence advantaged with low public awareness.

    Chakrabarti  said that “We find that inhibition of COP1 can significantly reduce liver fat in NAFLD. However, it is still not clear whether COP1 can halt disease progression or can prevent NASH. We are currently working in this direction.

    The study has been published in September in the journal Diabetes, from American Diabetes Association (ADA).

    According to CSIR-IICB Director Samit Chattopadhyay, the development will motivate the scientific community to come up with new solutions to this global problem and is “geared towards India’s goal of delivering translational research outputs to the nation.”

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Latest News

    WR revise timings of 15 more special trains from 1st December

    Western Railway has revised the timings of some more special trains of Western Railway from 1st December,...

    WR to extend the run of six more festive special trains with 96 additional services

    For the convenience of passengers and meet the travel demand, Western Railway has decided to further extend the running of 6 Festival...

    WR recovered ₹ 1.04 cr as penalty in intensive checking drives

    Western Railway’s Mumbai Division conducted various drives to check & deter unauthorized passengers travelling in trains. More than 25,900 cases were detected...

    29 November – Know your today’s horoscope

    Aries: Take complete rest to regain your energy as a feeble body weakens the mind You must realize your true potentials as...

    Konark cycling expedition 1971 enters third leg

    The team of SINDH BRIGADE comprising of two officers and 18 other ranks from Jamnagar Military station have taken forward the third...

    More Articles Like This

    - Advertisement -